Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIMEPREVIR vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIMEPREVIR vs SITAGLIPTIN: Safety Overview

Metric SIMEPREVIR SITAGLIPTIN
Total FAERS Reports 6,029 19,904
Deaths Reported 372 2,412
Death Rate 6.2% 12.1%
Hospitalizations 1,165 6,668
Average Patient Age 60.6 yrs 67.3 yrs
% Female Patients 43.0% 52.3%
FDA Approval Date Nov 22, 2013 Dec 30, 2025
Manufacturer N/A A-S Medication Solutions
Route N/A ORAL
Marketing Status Discontinued Prescription